Antony Koblish
Co-founder & Chief Executive Officer
Antony Koblish is a medical device entrepreneur with 25 years of experience in health care. Prior to founding TELA Bio, Mr. Koblish was President and Chief Executive Officer of Orthovita, Inc., a publicly traded orthobiologics and biosurgery medical device company. During his tenure as Chief Executive Officer of Orthovita from 2002 to 2011, Mr. Koblish created significant company value, growing valuation from $30M to a $316M exit sale to Stryker Corporation in 2011. He is a skilled leader with a proven track record in driving sales growth, building a robust product pipeline, establishing world-class commercial operations, and instilling clinical and manufacturing quality.
Mr. Koblish is a co-founder and currently serves as Chairman of the Board of Onkos Surgical, Inc., a surgical oncology company. He also serves on the Board of Directors of Spineology, pioneers of Conform and Expand™ technology, a novel development method used in the design of spinal expandable implants, and Cerapedics, a global, commercial-stage orthopedics company that is dedicated to redefining the path to bone repair by healing bones faster and at higher rates.
Mr. Koblish earned a Master of Science in Engineering degree in Mechanical Engineering and Applied Mechanics from the University of Pennsylvania and holds a Bachelor of Science degree in Mechanical Engineering from Worcester Polytechnic Institute.